ARCHIVES

NCI’s Schneiderman Reports Result Of Better Treatment, Some Drop In Incidence, Overall Increase As Kennedy Hearings Open

This article is from The Cancer Letter archive.

Vol. 05 No. 10 | March 9, 1979

Download PDF Visit The Full Archive

Related Articles

ECOG Subcontractors Critique Cancer Control Program

August 24, 1979

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

Hard imes For Cancer Control – Six Contracts Ended; Rochester’s Community Proposal Rejected

October 1, 1976

Rosenberg’s Adoptive Immunotherapy Update

December 6, 1985

Varmus’s 2016 Bypass Budget Seeks “Modest” Increase of $823 Million

December 5, 2014

Trifluridine and Tipiracil Hydrochloride Increase OS, PFS in Phase III Trial

July 25, 2014